SIRS-Lab appoints Ed Currie as Executive Vice-President, Corporate Development

06-Feb-2009 - Germany

SIRS-Lab announced the appointment of Dr. Edward Currie as Executive Vice-President, Corporate Development. In this newly created role, Ed will drive partnering, licensing, companion diagnostics, and corporate business development activities at SIRS-Lab.

SIRS-Lab

Ed Currie, SIRS-Lab Executive Vice-President, Corporate Development.

Ed Currie, a physician specialized in clinical microbiology and infectious disease, brings 20 years of diagnostic and pharmaceutical industry experience at Eli Lilly, F. Hoffmann-La Roche, IBM, and, most recently, as COO of Kuros BioSurgery. At Roche, as Global Head of Disease Management, Ed created the company’s first integrated Pharma-Diagnostic approach for targeted treatment and personalized medicine.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances